Signature Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Signature Financial Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$338K	Sell	6,502 -39,570	-86%	-$2.13M	0.08%	85
2018 Q3	$2.86M	Buy	46,072 +66	+0.1%	+$3.92K	0.51%	31
2018 Q2	$2.55M	Buy	46,006 +870	+2%	+$47K	0.54%	34
2018 Q1	$2.85M	Buy	45,136 +39,773	+742%	+$2.56M	0.59%	29
2017 Q4	$328K	Sell	5,363 -5,756	-52%	-$360K	0.09%	95
2017 Q3	$655K	Buy	11,119 +2,792	+34%	+$163K	0.2%	66
2017 Q2	$464K	Sell	8,327 -401	-5%	-$21.8K	0.15%	82
2017 Q1	$474K	Sell	8,728 -366	-4%	-$20.1K	0.15%	78
2016 Q4	$531K	Buy	9,094 +804	+10%	+$44K	0.2%	66
2016 Q3	$447K	Buy	8,290 +3,154	+61%	+$203K	0.18%	71
2016 Q2	$376K	Hold	5,136	–	–	0.18%	73
2016 Q1	$328K	Sell	5,136 -875	-15%	-$55.2K	0.16%	81
2015 Q4	$414K	Sell	6,011 -1,522	-20%	-$101K	0.2%	60
2015 Q3	$446K	Buy	7,533 +553	+8%	+$35.1K	0.27%	48
2015 Q2	$466K	Buy	6,980 +700	+11%	+$46.1K	0.3%	46
2015 Q1	$404K	Sell	6,280 -608	-9%	-$38.1K	0.26%	48
2014 Q4	$406K	Buy	6,888 +932	+16%	+$52.6K	0.28%	47
2014 Q3	$304K	Hold	5,956	–	–	0.22%	64
2014 Q2	$289K	Sell	5,956 -92	-2%	-$4.53K	0.22%	63
2014 Q1	$314K	Sell	6,048 -275	-4%	-$14.6K	0.27%	54
2013 Q4	$336K	Buy	6,323 +1,838	+41%	+$93.6K	0.26%	50
2013 Q3	$207K	Buy	+4,485	New	+$197K	0.18%	68

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Signature Financial Management's BMY Position: Q4 2018 in Review

Signature Financial Management reduced its Bristol-Myers Squibb (BMY) stake by 86% in Q4 2018, selling an estimated $2.13M and leaving 6,502 shares worth $338K. The position accounts for 0.08% of the portfolio, ranked #85.

Signature Financial Management first reported a position in BMY in Q3 2013 and has held it in 22 quarters since. The position peaked at $2.86M in Q3 2018. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Signature Financial Management held 6,502 shares of Bristol-Myers Squibb worth $338K as of Q4 2018.
Signature Financial Management sold 39,570 Bristol-Myers Squibb shares in Q4 2018, an estimated $2.13M.
Bristol-Myers Squibb made up 0.08% of Signature Financial Management's portfolio in Q4 2018, its #85 holding.
Signature Financial Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 22 quarters since.
Signature Financial Management's Bristol-Myers Squibb position peaked at $2.86M in Q3 2018.
1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Signature Financial Management's 13F filing for Q4 2018, filed 13 Feb 2019.